Colorcon launches Colorcon Academy
Industry leading further education programs unified and expanded.
Colorcon has launched the Colorcon Academy, an exciting new entity to build on the success of the company's highly valued education programs worldwide. Colorcon has provided speciality excipients for pharmaceutical and nutraceutical applications for nearly 60 years, and has always placed great emphasis to help customers optimize formulation development and manufacturing processes through its education events. The company's goal is to help clients achieve both outstanding technical and business outcomes.
Dr Ali Rajabi-Siahboomi, VP/Chief Scientific Officer, Colorcon said: “At Colorcon we are always striving to do something extra. This year, with the introduction of the Colorcon Academy, we’ve reorganized our highly valued education programs to advance our global standard in education. Under the new Colorcon Academy platform, we will offer the different programs at our 20 technical services facilities worldwide, in addition to events designed specifically for our customers, which are held at their site. Academy attendees have the opportunity to progress their skills in pharmaceutical sciences and become leaders in their own organizations at locations convenient to them.
"Since the first Colorcon Coating School in the 1980s, we have provided continuing education to thousands of customers around the world each year and continue to strengthen our commitment to advancing pharmaceutical technology and it’s applications.
"The Colorcon Academy program is designed to give pharmaceutical professionals a deeper knowledge of excipient functionality, core formulation, film coating and controlled release of oral solid dosage forms, along with regulatory insights; plus the opportunity to explore innovative solutions to formulation challenges.
"The thousands of course attendees have ranged from senior research scientists, to technology transfer scientists and process engineers. We receive very positive feedback from attendees and their managers, and continue to update and extend the content of the courses in line with changing industry needs. I am personally committed to the educational advances we provide and trust we continue to surpass attendees’ expectations with the launch of the Colorcon Academy,” concluded Dr Rajabi-Siahboomi.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance